ZHU, JIAWEI
 Distribuzione geografica
Continente #
NA - Nord America 103
EU - Europa 18
AS - Asia 9
Totale 130
Nazione #
US - Stati Uniti d'America 103
SE - Svezia 11
HK - Hong Kong 6
BG - Bulgaria 2
FI - Finlandia 2
LT - Lituania 2
SG - Singapore 2
CN - Cina 1
GB - Regno Unito 1
Totale 130
Città #
Fairfield 15
Chandler 13
Woodbridge 12
Ashburn 11
Nyköping 9
Seattle 8
Cambridge 6
Hong Kong 6
Ann Arbor 3
Houston 3
San Diego 3
Wilmington 3
Helsinki 2
Jacksonville 2
Princeton 2
Singapore 2
Sofia 2
London 1
Totale 103
Nome #
Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial 87
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study 48
Totale 135
Categoria #
all - tutte 1.018
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.018


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 23 19 0 3 2 4 3 0
2021/202227 0 4 0 0 3 1 2 0 4 0 10 3
2022/202336 5 6 4 1 6 3 0 5 5 0 1 0
2023/202418 0 1 1 1 1 2 2 5 0 0 3 2
Totale 135